Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: A pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression

Journal of Medical Virology

Volumn 82, Issue 2, 2010, Pages 311-320

  Kalantari, Mina ^a   Chase, Dana M ^a   Tewari, Krishnansu S ^a   Bernard, Hans Ulrich ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cervical cancer; Methylation; Pap test; Papillomavirus; Recombination

Indexed keywords

BISULFITE; CELL DNA; GLYCOPROTEIN L; L1 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA METHYLATION; DNA MODIFICATION; DNA RECOMBINATION; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MOLECULAR CLONING; NONHUMAN; PAPANICOLAOU TEST; PILOT STUDY; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX TUMOR; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS RECOMBINATION;

CAPSID PROTEINS; DNA METHYLATION; EPITHELIAL CELLS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; LIGASE CHAIN REACTION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 74549136674     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21676     Document Type: Article

References (44)

1. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM. 2006. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44:1755-1762.
2. Balderas-Loaeza A, Anaya-Saavedra G, Ramirez-Amador VA, Guido-Jimenez MC,Kalantari M, Calleja-Macias IE,BernardHU, Garcia-Carranca A. 2007. Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. Int J Cancer 120:2165-2169.
3. Bird A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev 16:6-21.
4. Briolat J, Dalstein V, Saunier M, Joseph K, Caudroy S, Pretet JL, Birembau P, Clavel C. 2007. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer 121:2198-2204.
5. Cantor SB, Cárdenas-Turanzas M, Cox DD, Atkinson EN, Nogueras-Gonzalez GM, Beck JR, Follen M, Benedet JL. 2008. Accuracy of colposcopy in the diagnostic setting compared with the screening setting. Obstet Gynecol 111:7-14.
6. Cox JT, Schiffman M, Solomon D. 2003. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among womenwith cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 188:1406-1412.
7. Daniel B, Rangarajan A, Mukherjee G, Vallikad E, Krishna S. 1997. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol 78:1095-1101.
8. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
9. Doerfler W, Remus R, Muller K, Heller H, Hohlweg U, Schubbert R. 2001. The fate of foreign DNA in mammalian cells and organisms. Dev Biol 106:89-97.
10. Fernandez AF, Rosales C, Lopez-NievaP,Graña O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF, Pino I, Javierre B, Carmona FJ, Acquadro F, Steenbergen RD, Snijders PJ,Meijer CJ, Pineau P, Dejean A, Lloveras B, Capella G, Quer J, ButiM, Esteban JI, Allende H, Rodriguez-Frias F, Castellsague X, Minarovits J, Ponce J, Capello D, Gaidano G, Cigudosa JC, Gomez-Lopez G, Pisano DG, Valencia A, Piris MA, Bosch FX, Cahir-McFarland E, Kieff E, Esteller M. 2009. The dynamic DNA methylomes of doublestranded DNA viruses associated with human cancer. Genome Res 19:438-451.
11. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89:1827-1831.
12. Guido R, Schiffman M, Solomon D, Burke L. 2003. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: A two-year prospective study. Am J Obstet Gynecol 188:1401- 1405.
13. Häfner N, Driesch C, Gajda M, Jansen L, Kirchmayr R,Runnebaum IB, Dü rst M. 2008. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 27:1610-1617.
14. Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF. 2004. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: Different levels of viral integration are correlated with lesion grade. Gynecol Oncol 92:873-880.
15. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. 2008. Cancer statistics, 2008. CA Cancer J Clin 58:71-96.
16. Jeon S, Allen-Hoffmann BL, Lambert PF. 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69:2989-2997.
17. Kalantari M, Blennow E, Hagmar B, Johansson B. 2001. Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol 10:46-54.
18. Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Barrera-Saldana HA, Wiley DJ, Bernard HU. 2004. Conserved methylation patterns of human papillomavirus-16 DNA in asymptomatic infection and cervical neoplasia. J Virol 78:12762-12772.
19. Kalantari M, Lee D, Calleja-Macias IE, Lambert P, Bernard HU. 2008a. Effects of cellular differentiation, chromosomal integration, and 50-aza-20-deoxycyticine treatment onhumanpapillomavirus-16 DNA methylation in cultured cell lines. Virology 374:292-303.
20. Kalantari M, Villa LL, Calleja-Macias IE, Bernard HU. 2008b. Human papillomavirus-16 and 18 in penile carcinomas: DNA methylation, chromosomal recombination, and genomic variation. Intern J Cancer 123:1832-1840.
21. Kim JJ, Wright TC, Goldie SJ. 2002. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 287:2382-2390.
22. Kim K, Garner-Hamrick PA, Fisher C, Lee D, Lambert PF. 2003. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 77:12450-12459.
23. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, Lotz B, Melsheimer P, von Knebel Doeberitz M. 1999. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59:6132-6136.
24. Kraus I, Driesch C, Vinokurova S, Hovig E, Schneider A, von Knebel Doeberitz M, Dürst M. 2008. The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res 68:2514-2522.
25. Kulmala SM, Syrjänen SM, Gyllensten UB, Shabalova IP, Petrovichev N, Tosi P, Syrjänen KJ, Johansson BC. 2006. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 59:513-517.
26. Luft F, Klaes R, Nees M, Durst M, Heilmann V, Melsheimer P, von Knebel Doeberitz M. 2001. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 92:9-17.
27. Manos MM, Waldman J, Zhang TY, Greer CE, Eichinger G, Schiffman MH, Wheeler CM. 1994. Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis 170:1096-1099.
28. Munoz N,Bosch FX, de SanjoséS, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM. 2003. Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
29. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB. 2000. Accuracy of the Papaniolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 132:810-819.
30. Naucler P, RydW, Törnberg S, Strand A, Wadell G, Elfgren K, Ra° dberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, Dillner J. 2007. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357:1589-1597.
31. Raab SS, Grzybicki DM, Zarbo RJ, Jensen C, Geyer SJ, Janosky JE, Meier FA, Vrbin CM, Carter G, GeisingerKR. 2007. Frequency and outcome of cervical cancer prevention failures in the United States. Am J Clin Pathol 128:817-824.
32. Smits HL, Tieben LM, Tjong-A-Hung SP, Jebbink MF, Minnaar RP, Jansen CL, Jan ter Schegget J. 1992. Detection and typing of human papillomaviruses present in fixed and stained archival cervical smears by a consensus polymerase chain reaction and direct sequence analysis allow the identification of a broad spectrum of human papillomavirus types. J Gen Virol 73:3263-3268.
33. Stoler MH, Schiffman M. 2001. Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistica estimates from the ASCUS-LSIL Triage Study. JAMA 285:1500-1505.
34. Stünkel W, Huang Z, Tan SH,O'ConnorM,Bernard HU. 2000. Nuclear matrix attachment regions of human papillomavirus-16 repress or activate theE6promoter depending on the physical state of the viral DNA. J Virol 74:2489-2501.
35. Tan SH, Leong LEC, Walker PA, Bernard HU. 1994. The human papillomavirus type 16 transcription factor E2 binds with low cooperativity to two flanking binding sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol 68:6411- 6420.
36. Tewari KS, Taylor JA, Liao SY, DiSaia PJ, Burger RA, Monk BJ, Hughes CC, Villarreal LP. 2000. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model. Gynecol Oncol 77:137-148.
37. Turan T, Kalantari M, Calleja-Macias IE, Villa LL, Cubie HA, Cuschieri K, Skomedal H, Barrera-Saldana HA, Bernard HU. 2006. Methylation of the human papillomavirus-18 L1 gene: A biomarker of neoplastic progression? Virology 349:175-183.
38. Turan T, Kalantari M, Cuschieri K, Cubie HA, Skomedal H, Bernard HU. 2007. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology 361:185-191.
39. Ueda Y, Enomoto T, Miyatake T, Ozaki K, Yoshizaki T, Kanao H, Ueno Y, Nakashima R, Shroyer KR, Murata Y. 2003. Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: Association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia. Lab Invest 83:1517-1527.
40. Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, Steenbergen RD, Meijer CL, Snijders PJ, Chatis P, Broker TR, Moen PT, Jr., Chow LT. 2004. Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol 78:11172-11186.
41. Vinokurova S,Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P,Kisseljov F,Dürst M,Schneider A, von Knebel Doeberitz M. 2008. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 68:307-313.
42. von Knebel Doeberitz M. 2002. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 38:2229-2242.
43. Wiley DJ, Huh J, Chang C, Kalantari M, Rao JY, Goetz M, Msongsong E, Poulter M, Bernard HU. 2005. Methylation of human papillomavirus DNA in samples of HIV-1 infected men screened for anal cancer. J Acquir Immune Defic Syndr 39:143-151.
44. zur Hausen H. 2001. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2:342-350.